In light of this, an HSA-based nanodrug co-loaded with the anti-RA medication MTX and the ROS scavenger superoxide dismutase (SOD) was designed, and is now known as HSA-SOD-MTX [71]. The gene discussed is ALB; the disease is rheumatoid arthritis.